NACDS stresses need for a ‘comprehensive solution’ to prescription drug abuse

The National Association of Chain Drug Stores announced that the Orlando Sentinel published a letter to the editor from NACDS president and CEO Steve Anderson that outlines the way pharmacists approach complex prescription pain medication issues. Read more ...

FDA approves first generic versions of Abilify

The Food and Drug Administration announced approval for the first generic versions of the antipsychotic drug Abilify (aripiprazole). Read More ...

DSN, higi introduce first-ever Fit Pharmacist Challenge

Drug Store News, in partnership with higi, is hosting the first-ever Fit Pharmacist Challenge, a series of fitness-tracking competitions that will reward winning pharmacists and pharmacy technicians for logging the most miles. Read More ...

Survey: More than 50% of ACS patients do not follow prescribed OAP regimen

A recent Harris Poll survey found that 52% of 275 ACS patients currently taking an OAP missed taking or changed the way they take their prescribed OAP therapy, even after being informed by their doctors of its importance. Read More ...

Current news

Osteoporosis, as a disease, is often identified through an event.
Worldwide, osteoporosis causes over 8.9 million fractures each year, which equates to a fracture every three seconds.
Pharmacists should take on an active a role in informing all patients, especially women, of the many lifestyle changes and screening tests available to assist with prevention and diagnosis of osteoporosis.
There are several methods to prevent, slow or halt the progress of osteoporosis.
Anyone who needs a little white noise to get to sleep can now turn to their smartphone, thanks to the Sleep Pillow Sounds app.
The National Association of Chain Drug Stores on Wednesday announced that the Orlando Sentinel published a letter to the editor from NACDS president and CEO Steve Anderson that outlines the way pharmacists approach complex prescription pain medication issues.
The Food and Drug Administration on Tuesday announced approval for the first generic versions of Abilify (aripiprazole) tablets, an antipsychotic drug indicated for the treatment of schizophrenia and bipolar disorder.
Teva Pharmaceutical announced the launch of aripiprazole tablets in 2-, 5-, 10-, 15, 20- and 30-mg strengths in the United States.
To support the efforts of today’s community pharmacy preceptors and to assist in the development of future community practice preceptors, Drug Store News is featuring a monthly Community Pharmacy Preceptor Spotlight.
Because many pharmacies across the country have already implemented patient-focused services that can impact pharmacy quality and performance Drug Store News has created a monthly forum for sharing best practices and spot-lighting pharmacy teams who are leading the way.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at MyCPEMonitor.net.

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the MyCPEMonitor.net or NABP.net site and search the system for their NABP e-PID number.